“Two to 4% of cancers respond to chemotherapy....The bottom line is for a few kinds of cancer chemo is a life extending procedure-Hodgkin's disease, Acute Lymphocytic Leukemia (ALL), Testicular cancer, and Choriocarcinoma.” KindTwoLinesDiseaseBottomCancerBottom LineProceduresExtendingChemotherapyLeukemiaTesticular Cancer Author:Ralph W. Moss
“1.7% increase in terms of success rate a year, its nothing. By the time we get to the 24 century we might have effective treatments, Star Trek will be long gone by that time.” YearsLongMightStarsTermGoneCenturyIncreaseRateTreatmentChemotherapy Author:Ralph W. Moss
“If cancer specialists were to admit publicly that chemotherapy is of limited usefulness and is often dangerous, the public might demand a radical change in direction-possibly toward unorthodox and nontoxic methods, and toward cancer prevention. ...The use of chemotherapy is even advocated by those members of the establishment who realize how ineffective and dangerous it can be.” IfsUseMightRealizingDangerousDemandMembersMethodCancerRadicalEstablishmentUsefulnessSpecialistsPreventionChemotherapyRadical ChangeUnorthodox Book:The Cancer Industry: The Classic Exposé on the Cancer Establishment Source: The Cancer Industry: The Classic Exposé on the Cancer Establishment
“A study was done which shows the majority of oncologists who refer patients for chemotherapy for lung cancer would not themselves take chemotherapy for lung cancer. And in fact if the chemotherapy involved cis-platen, something like 75% of them said they wouldn't take it. But what do these people do all day long? They're sending people for cis-platen.” PeopleIfsLongSaidDoneFactsShowsStudyInvolvedMajorityPatientCancerLungsChemotherapyLung CancerOncologists Author:Ralph W. Moss
“The great success stories of chemotherapy were always in relatively obscure types of cancer. Childhood leukemia constitutes less than two percent of all cancers and many of chemotherapy's other successes were in diseases so rare that many clinicians had never even seen a single case” TwoStoriesCasesChildhoodTypeDiseasePercentCancerObscureGreat SuccessSuccess StoriesChemotherapyLeukemiaClinicians Author:Ralph W. Moss
